EWM
VIVS

Elite Wealth Management’s VivoSim Labs VIVS Stock Holding History

Elite Wealth Management’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-8
Closed -$15K – 490
2014
Q1 		$15K Buy
8
+4
+100% +$9.29K 0.01% 218
2013
Q4 		$11K Buy
+4
New +$7.85K 0.01% 348

Other funds holding VIVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CNB
City National Bank Beverly Hills, California $11.6B AUM 3.11% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Elite Wealth Management's VIVS Position: Q2 2014 in Review

Elite Wealth Management sold out of VivoSim Labs (VIVS) in Q2 2014, closing a stake of 8 shares — an estimated $15K sold.

Elite Wealth Management first reported a position in VIVS in Q4 2013 and held it in 2 quarters. The position peaked at $15K in Q1 2014. 115 funds tracked by Wall St. Rank hold VIVS as of Q2 2014.

  • Elite Wealth Management reported no remaining VivoSim Labs position as of Q2 2014 after selling out during the quarter.
  • Elite Wealth Management sold 8 VivoSim Labs shares in Q2 2014, an estimated $15K.
  • Elite Wealth Management first reported a position in VivoSim Labs in Q4 2013 and held it in 2 quarters.
  • Elite Wealth Management's VivoSim Labs position peaked at $15K in Q1 2014.
  • 115 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2014.

Based on Elite Wealth Management's 13F filing for Q2 2014, filed 23 Nov 2016.